Collaborators


External collaborators

James Roberts, M.D.,  Professor, Department of Obstetrics, Gynecology & Reproductive Sciences at The University of Pittsburg.

Dr. Roberts' research is interdisciplinary and involves fundamental, clinical, behavioral, global and epidemiological studies. He has been involved in several seminal studies of preeclampsia including the recognition of preeclampsia as involving endothelial dysfunction and being more than hypertension in pregnancy. He was protocol chair of the NIH trial (10,000 women) of vitamins C and E given to prevent preeclampsia. He currently heads the Global Pregnancy Collaboration, a consortium of 36 centers worldwide to facilitate collaborative research and research in low resource settings. Find out more about Dr. Roberts.

Kang Sun, M.D., Ph.D., Professor, Shanghai Jiao Tong University School of Medicine. 

Dr. Sun's endeavor to uncover the roles of the unique endocrine/paracrine features of the fetal membranes in labor onset and membrane rupture by using human fetal membrane tissue and cells. The aim of our study is to seek novel approaches to the prevention of  preterm birth through elucidation of  the endocrine/paracrine functions of the fetal membranes. Find out more about Dr. Sun.

Alison Paquette, Ph.D., Assistant Professor, Seattle Children's Research Institute's Center for Developmental Biology and Regenerative Medicine, Department of Pediatrics University of Washington.

Dr. Paquette uses computational biology approaches to study how the prenatal environment influences infant and child health outcomes. Find out more about Dr. Paquette. 

Stephen Lye, Ph.D., Professor of Obstetrics and Gynecology University of Toronto, Senior Principal Investigator & Institute Director of Lunenfeld-Tanenbaum Research Institute. 

Dr. Stephen Lye is a recognized leader in the field of women's and infants' health. His research holds promise for a new understanding of preeclampsia, a leading global cause of maternal and infant illness and death. In addition, his lab has conducted pre-clinical trials of a drug to stop uterine contractions, which is now being tested on patients in preterm labor at Mount Sinai Hospital. Find out more about Dr. Lye.

Mark Johnson, MBBS., Ph.D., Professor of Obstetrics and Gynecology Imperial College University of London.

Dr. Johnson works to identify treatment modalities that will prevent or reduce the risk of preterm labour and its inflammatory consequences in the fetus, understand how the maternal immune system contributes to the onset of preterm labour, and understand how pregnancy influences the progress of pre-existing heart disease and define the optimal management strategies for these complex cases. Find out more about Dr. Johnson.

Tom Metz, Ph.D., Metabolomics Team Lead, Pacific Northwest National Laboratories 

His research interests span the development of both untargeted and targeted metabolomics and lipidomics capabilities, based on liquid and gas chromatography coupled with mass spectrometry, both for fundamental studies of metabolism and metabolic interactions (e.g., among microbial communities), as well as for biomarker discovery, with a primary emphasis on studies of diabetes mellitus and infectious diseases, resulting in over 120 publications to date. Find out more about Dr. Metz.

Kristin Burnum-Johnson, Ph.D., Metabolomics Team Lead, Pacific Northwest National Laboratories 

Burnum-Johnson has over a decade of experience and more than 50 publications dedicated to the development and evaluation of in situ imaging MS, structural characterization of molecules using ion mobility-MS, and analyses of molecules in complex matrices using high-resolution MS. Find out more about Dr. Burnum-Johnson.

Wayne Wakeland, Ph.D.,  Professor at the Systems Science Program in Portland State University.

Dr. Wakeland earned a B.S. and a Master of Engineering at Harvey Mudd College (1973); and a Ph.D. in Systems Science at Portland State U. (1977). His primary methods involve computer simulation, and his current research focuses on recovery from concussion; health policy related to drug diversion, abuse and treatment; applied data mining; and environmental/ecological sustainability. Find out more about Dr. Wakeland.